T. Rowe Price Health Sciences (PRHSX)
50.14
0.26(0.52%) May 23
| Prev Close: | 49.88 |
|---|
| YTD Return*: | 9.24% |
|---|
| Net Assets*: | 5.78B |
|---|
| Yield*: | 0.30% |
|---|
* As of 28-Feb-13
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- A Manager's Departureat The Wall Street Journal(Sun, Apr 7)
- Reverse AlchemyMorningstar(Tue, Feb 26)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Thu, Jan 24)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Wed, Jan 2)
- Top 5 Zacks#1 Ranked T. Rowe Price Mutual FundsZacks(Tue, Dec 18)
- Top 5 Zacks #1 Ranked Energy Mutual FundsZacks(Tue, Dec 18)
- [video] Gilead, Edwards Offer Healthy 2013 Returnsat TheStreet(Mon, Nov 26)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Fri, Nov 23)
- Health Care Funds That Can Continue Rallyingat TheStreet(Fri, Nov 2)
- Health Care Funds That Can Continue RallyingTheStreet(Fri, Nov 2)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Mon, Oct 29)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Oct 17)
- Zacks#1 Ranked Healthcare Mutual FundsZacks(Thu, Sep 13)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Sep 5)
- [video] Insuring Your Investmentsat CNBC(Fri, Aug 24)
Fund Basics
| Morningstar Overall Rating: | |
| Total Assets: | 5.78B |
| Category: | Health |
|---|
| Annual Report Expense Ratio (net): | 0.79% |
|---|
Performance & Risk
| YTD Return: | 9.24% |
| 5y Avg Return: | 13.72% |
| Rank in Category (ytd): | 43 |
| % Rank in Category (ytd): | 30.71% |
| Beta (3y): | 0.82 |
| Morningstar Risk Rating: | 3 |
Fund Summary
The investment seeks long-term capital appreciation.
The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While it can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. The fund may invest in foreign stocks and options in keeping with the fund's objectives.
View More